Dokumendiregister | Terviseamet |
Viit | 8.1-2/24/9792-1 |
Registreeritud | 30.09.2024 |
Sünkroonitud | 01.10.2024 |
Liik | Sissetulev dokument |
Funktsioon | 8.1 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
Sari | 8.1-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
Toimik | 8.1-2/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | STIHIVHEP |
Saabumis/saatmisviis | STIHIVHEP |
Vastutaja | Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond) |
Originaal | Ava uues aknas |
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear Colleagues,
I am reaching out to clarify some details regarding tables 12 and 17 included in the last link for validation.
Link to tables: [
ECDC-WHO data 2023 HIV Report Tables _25 _Sep_2024.xlsx]
I apologize for any miscommunication and hope this does not cause any inconvenience during the validation process. I will wait for your comments until tomorrow; if I do not hear back, I will assume you agree with the tables as they are.
Thank you, and apologies again for any confusion caused.
Kind regards,
Juliana Reyes, on behalf of
WHO and ECDC HIV surveillance teams
|
Classified as ECDC NORMAL
Classified as ECDC NORMAL
Dear Colleagues,
Thank you very much for taking the time to validate the data and for those who have submitted and uploaded new datasets.
I am attaching below a new link with an updated set of tables for your review and validation, specifically for Table 12. We are now excluding previous positive cases and children under 15 years old, which were not excluded in the previous analysis. As a result, the table had to be revised, and I kindly ask for your feedback on this new version.
Link [
ECDC-WHO data 2023 HIV Report Tables _25 _Sep_2024.xlsx]
Please leave your comments directly on the tables, as this will help us track who has provided input and when. I kindly request your comments and suggestions by Monday, the 30th. I apologize in advance for the short notice, but we are slightly behind schedule on the report production process we established with WHO this year.
Additionally, I would kindly ask Ireland, Denmark, Portugal, and Liechtenstein to review their data in the tables, as the new dataset uploads have been included in TESSy.
Thank you once again for all your contributions and support.
Kind regards,
Juliana, on behalf of
WHO and ECDC HIV surveillance teams
|
Classified as ECDC NORMAL
From:
STIHIVHEP
Sent: Friday, September 13, 2024 2:29 PM
To: [email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; derval.igoe <[email protected]>;
[email protected]; dominique.vanbeckhoven <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; Guðrún Aspelund - Landl <[email protected]>;
[email protected];
[email protected]; [email protected]; jessika.deblonde <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected]; Helena Cortes Martins <[email protected]>; Lilian Van Leest <[email protected]>
Cc: Anastasia Pharris <[email protected]>; KUCHUKHIDZE, Giorgi <[email protected]>; Juliana Reyes <[email protected]>;
Country Support <[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected]; dominique.vanbeckhoven <[email protected]>; jessika.deblonde <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected]; hana.zakoucka <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected]; [email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected]; molnar.zsuzsanna <[email protected]>;
[email protected]; molnar.zsuzsanna <[email protected]>; Guðrún Aspelund - Landl <[email protected]>;
[email protected];
[email protected];
[email protected]; Guðrún Aspelund - Landl <[email protected]>;
[email protected];
[email protected];
[email protected]; [email protected]; derval.igoe <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; vilnele.lipnickiene <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected]; Patrick HOFFMANN <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected]; Rosinska Magdalena <[email protected]>; Rui Tato Marinho <[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected]; eva.chmelanova <[email protected]>;
[email protected];
[email protected]; [email protected]; tanja.kustec <[email protected]>;
[email protected];
[email protected]; [email protected]; jamo <[email protected]>;
[email protected];
[email protected]; maria.axelsson <[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected]; [email protected];
[email protected]; Christakis Chatzichristodoulou <[email protected]>;
[email protected];
[email protected]; [email protected]; Guðrún Aspelund - Landl <[email protected]>;
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected]; [email protected]; Heidi Lange <[email protected]>;
[email protected];
[email protected];
[email protected]; [email protected];
[email protected];
[email protected];
[email protected]; [email protected];
[email protected]; [email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; anette.richardson <[email protected]>;
[email protected]
Subject: For country review: ECDC/WHO 2024 HIV Surveillance report- 2023 data
Dear Colleagues,
First of all, many thanks for your excellent and greatly appreciated support to the deadline for submission of HIV and AIDS data for the forthcoming 2024 HIV/AIDS Surveillance in Europe report, 2023 data.
This is the
link
to the files containing the set of tables with HIV and AIDS data from countries whose submissions through TESSy are sufficiently validated. We kindly ask you to review the data for your country as presented in the tables. Please note that all report
tables containing country-specific data are included for your review, while tables with data grouped by countries will be produced later. Additionally, please don't forget to review and update the information in Annexes 4, 5, and 6.
We encourage you to use the provided link to consolidate all comments into one file. However, if you do not have access to the link or encounter any issues, please let me know and use the attached file instead. The attached file should only be used if the link is not functioning for you.
If you have not already done so, we also ask you to please upload the number of HIV tests performed in your country during 2023.
Please check your data in the tables, send us your comments and complete any potential resubmissions by 20 September 2023, to make sure that your data will appear correctly in the 2024 report.
With thanks and best regards,
Juliana and Giorgi, on behalf of
WHO and ECDC HIV surveillance teams
|
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
**********************************************************************
The information contained in this e-mail transmission may be confidential. It is intended only for the addressee(s) stated above.
If you are not an addressee, any use, dissemination, distribution, publication, or copying of the information contained in this e-mail is strictly prohibited. If you have received this e-mail in error, please immediately notify us by telephone at
353-1-8765300 or e-mail [email protected] and delete the email from your system.
This footnote also confirms that this email message has been scanned for the presence of computer viruses.
**********************************************************************